Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TGTX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
TGTX
TG Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
TGTX
TG Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TGTX, solid
LLY, dashed
TGTX
TG Therapeutics, Inc.
Change
57.94
▼
−5.98%
· post 57.95
· delayed
Mkt cap
$9.4B
Revenue
$240M
Q2 FY26
Revenue
$616M
FY25
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,366.80
· delayed
After hours
Nov 5 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 5 '26
delayed
TGTX
TG Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
57.94
▼
−5.98%
post 57.95
delayed
Price
1,371.32
▼
−3.29%
post 1,366.80
delayed
$9.4B
Mkt cap
$1.3T
Q2 FY26
$240M
Revenue
$24.4B
Q3 FY26
FY25
$616M
Revenue
$65.2B
FY25
Change
Change
TGTX
57.94
▼
−5.98%
vs
LLY
1,371.32
▼
−3.29%
After hours
Nov 5 '26
delayed